SUBSTITUTED 1-OXO- AND 1,3-DIOXOISOINDOLINES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS FOR REDUCING INFLAMMATORY CYTOKINE LEVELS
申请人:CELGENE CORPORATION
公开号:EP1163219A1
公开(公告)日:2001-12-19
US6380239B1
申请人:——
公开号:US6380239B1
公开(公告)日:2002-04-30
[EN] SUBSTITUTED 1-OXO- AND 1,3-DIOXOISOINDOLINES AND THEIR USE IN PHARMACEUTICAL COMPOSITIONS FOR REDUCING INFLAMMATORY CYTOKINE LEVELS<br/>[FR] 1-OXO- ET 1,3-DIOXOISOINDOLINES SUBSTITUEES ET LEUR UTILISATION DANS DES COMPOSITIONS PHARMACEUTIQUES AFIN DE REDUIRE LES TAUX DE CYTOKINES INFLAMMATOIRES
申请人:CELGENE CORP
公开号:WO2000055134A1
公开(公告)日:2000-09-21
1-Oxo- and 1,3-dioxoisoindolines substituted in the 4- or 5-position of the indoline ring reduce the levels of inflammatory cytokines such as TNFα in a mammal. A typical embodiment is 4-(4-amino-1,3-dioxoisoindolin-2-yl)-4-carbamoylbutanoic acid.